The March formulary updates include the addition of 52 new National Drug Codes (NDCs), representing 37 different prescription drugs, many with multiple strengths.
The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).
Highlights of the March 2022 Formulary update include twelve (12) newly-added brand-name drugs
The March drug data updates include twenty-two (22) new brand-name drugs, twelve (12) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
- BESREMI®,
- CENTANY®,
- EPRONTIA®,
- EXKIVITY®,
- LIVMARLI®,
- LIVTENCITY®,
- OPZELURA®,
- QULIPTA®,
- SCEMBLIX®,
- TICOVAC®,
- TRUDHESA®, and
- VUITY®.
The March 2022 Formulary update includes three (3) newly-added generic drugs
The March Medicare Part D drug data also includes fifteen (15) new generic medications, three (3) of which are newly-introduced generic drugs. These new generic drugs include:
- CLORAZEPATE [TRANXENE T-TAB®],
- CLORAZEPATE [TRANXENE®], and
- ROSUVASTATIN-EZETIMIBE [ROSZET®].
Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.
Reminders about Medicare prescription drug plan formulary changes
- Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.
- Your Medicare Part D plan
will notify you if the plan drops a medication you are currently using.
The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging. You can read more on this site
Summary of March 2022 NDC changes
There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 52 new March 2022 NDCs is as follows:
| Reason for NDC Addition | Occurrences |
| New Drug | 15 |
| New Drug and Strength | 20 |
| New Manufacturer and Delivery Form | 2 |
| New Manufacturer and Strength | 4 |
| New Manufacturer, Strength and Delivery Form | 1 |
| New Strength | 10 |
| Grand Total | 52 |
The following chart details the 52 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.
You can click on the Drug Name below to go to our on this site Drug Finder ( on this site) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state). You can then change the state in our search form for details of drug coverage in your service area.
| NDC | Drug Name | Number of PDP Formularies* |
Number of MAPD Formularies* |
Notes |
| 00071311223 | ACCURETIC 10-12.5 MG TABLET | 2 | 3 | New Strength |
| 00071521223 | ACCURETIC 20-12.5 MG TABLET | 2 | 3 | New Strength |
| 51672138409 | ADAPALENE-BNZYL PEROX 0.3-2.5% GEL W/PUMP [Epiduo] | 1 | 12 | New Strength |
| 73536050001 | BESREMI 500 MCG/ML SYRINGE | 57 | 376 | New Drug |
| 43538030030 | CENTANY 2% OINTMENT | 0 | 4 | New Drug |
| 13107032001 | CLORAZEPATE 7.5 MG TABLET [Tranxene T-Tab] | 63 | 402 | New Drug and Strength |
| 13107032101 | CLORAZEPATE 15 MG TABLET [Tranxene] | 63 | 403 | New Drug and Strength |
| 13107031901 | CLORAZEPATE 3.75 MG TABLET [Tranxene] | 63 | 402 | New Drug and Strength |
| 50222026006 | DOVONEX 0.005% CREAM (G) | 2 | 2 | New Drug |
| 63304061501 | DOXYCYCLINE MONO 75 MG CAPSULE [Okebo] | 12 | 74 | New Drug |
| 00024591102 | DUPIXENT 100 MG/0.67 ML SYRINGE | 38 | 272 | New Strength |
| 61958220501 | EPCLUSA 150-37.5 MG PELLET PACK | 36 | 223 | New Manufacturer and Delivery Form |
| 61958220401 | EPCLUSA 200-50 MG PELLET PACK | 36 | 223 | New Manufacturer and Delivery Form |
| 52652900101 | EPRONTIA 25 MG/ML SOLUTION | 38 | 348 | New Drug |
| 67877072131 | EVEROLIMUS 1 MG TABLET [Zortress] | 62 | 402 | New Manufacturer and Strength |
| 63020004012 | EXKIVITY 40 MG CAPSULE | 63 | 403 | New Drug |
| 16729056101 | HYDROXYCHLOROQUINE 100 MG TABLET | 13 | 147 | New Drug and Strength |
| 16729056201 | HYDROXYCHLOROQUINE 300 MG TABLET | 13 | 104 | New Drug and Strength |
| 16729056301 | HYDROXYCHLOROQUINE 400 MG TABLET | 13 | 104 | New Drug and Strength |
| 61269060510 | KLONOPIN 0.5 MG TABLET | 0 | 1 | New Manufacturer and Strength |
| 61269062010 | KLONOPIN 2 MG TABLET | 0 | 1 | New Manufacturer and Strength |
| 62559030690 | LIPOFEN 150 MG CAPSULE | 1 | 39 | New Drug |
| 79378011001 | LIVMARLI 9.5 MG/ML ORAL SOLUTION | 6 | 65 | New Drug |
| 64764080056 | LIVTENCITY 200 MG TABLET | 7 | 66 | New Drug |
| 13107008499 | LORAZEPAM 1 MG TABLET [Ativan] | 63 | 403 | New Manufacturer and Strength |
| 51862064801 | MICROGESTIN 24 FE 1 MG-20 MCG TABLET [Tarina Fe 1/20] | 37 | 216 | New Strength |
| 00781717612 | NALOXONE HCL 4 MG NASAL SPRAY [Narcan] | 51 | 359 | New Manufacturer, Strength and Delivery Form |
| 54436032530 | NOCDURNA 27.7 MCG TABLET SL TABLET RAPDIS | 0 | 37 | New Drug and Strength |
| 54436035030 | NOCDURNA 55.3 MCG TABLET SL TABLET RAPDIS | 0 | 37 | New Drug and Strength |
| 65862089888 | NYLIA 1-35 28 TABLET [Pirmella] | 55 | 352 | New Strength |
| 50881000705 | OPZELURA 1.5% CREAM (G) | 1 | 25 | New Drug |
| 72786011103 | OXBRYTA 300 MG TABLET FOR SUSP | 8 | 111 | New Strength |
| 72887068203 | OXYCODONE-ACETAMINOPHEN 7.5-300 TABLET [Prolate] | 2 | 9 | New Strength |
| 60505437803 | PAXIL CR 25 MG TABLET ER 24H | 0 | 1 | New Strength |
| 43598063401 | PENICILLAMINE 250 MG CAPSULE [Cuprimine] | 4 | 89 | New Drug |
| 66993084435 | PREDNISOLONE ODT 10 MG TABLET RAPDIS [Orapred ODT] | 4 | 110 | New Drug and Strength |
| 66993084535 | PREDNISOLONE ODT 15 MG TABLET RAPDIS [Orapred ODT] | 4 | 112 | New Drug and Strength |
| 66993084635 | PREDNISOLONE ODT 30 MG TABLET RAPDIS [Orapred ODT] | 4 | 110 | New Drug and Strength |
| 00074709530 | QULIPTA 10 MG TABLET | 0 | 8 | New Drug and Strength |
| 00074709630 | QULIPTA 30 MG TABLET | 0 | 8 | New Drug and Strength |
| 00074709430 | QULIPTA 60 MG TABLET | 0 | 8 | New Drug and Strength |
| 82120012630 | ROSUVASTATIN-EZETIMIBE 10-10MG TABLET [ROSZET] | 0 | 12 | New Drug and Strength |
| 82120012730 | ROSUVASTATIN-EZETIMIBE 20-10MG TABLET [ROSZET] | 0 | 12 | New Drug and Strength |
| 82120012830 | ROSUVASTATIN-EZETIMIBE 40-10MG TABLET [ROSZET] | 0 | 12 | New Drug and Strength |
| 82120012530 | ROSUVASTATIN-EZETIMIBE 5-10 MG TABLET [ROSZET] | 0 | 12 | New Drug and Strength |
| 00078109120 | SCEMBLIX 20 MG TABLET | 63 | 403 | New Drug and Strength |
| 00078109820 | SCEMBLIX 40 MG TABLET | 63 | 403 | New Drug and Strength |
| 43538092060 | SYNALAR 0.01% SOLUTION | 0 | 1 | New Drug |
| 00069041102 | TICOVAC 2.4 MCG/0.5 ML SYRINGE | 54 | 314 | New Drug |
| 60505265901 | TRAZODONE 300 MG TABLET [Desyrel] | 48 | 260 | New Strength |
| 77530072504 | TRUDHESA NASAL SPRAY/PUMP | 2 | 21 | New Drug |
| 00074709804 | VUITY 1.25% EYE DROPS | 0 | 4 | New Drug |
You can review any Medicare plan formulary using the on this site Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at on this site.